Cargando…
Effects of Vitamin D(3) and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial
Background: The VITAL study was a nationwide, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial of vitamin D(3) (2000 IU/day) and marine n-3 FAs (1 g/day) supplements. We recently reported that vitamin D supplementation with or without omega 3 fatty acids reduced autoimmune disease...
Autores principales: | Dong, Yanbin, Zhu, Haidong, Chen, Li, Huang, Ying, Christen, William, Cook, Nancy R., Copeland, Trisha, Mora, Samia, Buring, Julie E., Lee, I-Min, Costenbader, Karen H., Manson, JoAnn E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782648/ https://www.ncbi.nlm.nih.gov/pubmed/36558465 http://dx.doi.org/10.3390/nu14245307 |
Ejemplares similares
-
Effects of Vitamin D(3) Supplementation on Body Composition in the VITamin D and OmegA-3 TriaL (VITAL)
por: Chou, Sharon H, et al.
Publicado: (2021) -
Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial
por: Hahn, Jill, et al.
Publicado: (2022) -
Effects of Supplemental Vitamin D on Bone Health Outcomes in Women and Men in the VITamin D and OmegA‐3 TriaL (VITAL)
por: LeBoff, Meryl S, et al.
Publicado: (2020) -
VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D Supplements on Risk of Falls in the US Population
por: LeBoff, Meryl S, et al.
Publicado: (2020) -
A randomized clinical trial of omega-3 fatty acid and vitamin D supplementation on electrocardiographic risk profiles
por: Tikkanen, Jani T., et al.
Publicado: (2023)